Childhood Cancer Insights and Comparisons
Uploaded by
MhynieChildhood Cancer Insights and Comparisons
Uploaded by
MhynieCommon questions
Powered by AIAccess to essential medicines, pathology, blood products, radiation therapy, and psychosocial support is inequitable globally. WHO aims to address these disparities through the Global Initiative for Childhood Cancer, which includes developing high-quality cancer programs, increasing political commitment, developing standards and tools, and improving access to essential medicines and technologies. These efforts seek to achieve universal health coverage and reduce premature mortality from non-communicable diseases .
WHO's efforts to reduce disparities in childhood cancer care, such as the Global Initiative for Childhood Cancer, are significant as they aim to achieve universal health coverage and equitable access to treatment across all income settings. By improving access to quality cancer treatment and care, these initiatives are anticipated to diminish inequities in survival rates and improve outcomes globally, thus enhancing global health equity .
Chemotherapy, surgery, and radiotherapy are standard treatments for childhood cancer. Chemotherapy involves using drugs to destroy cancer cells, surgery involves removing tumors, and radiotherapy uses radiation to kill or damage cancer cells. A multidisciplinary care team is crucial as it integrates different specialists to provide comprehensive care, address all patient needs, and improve treatment outcomes .
Benign neoplasms consist of cells that resemble normal cells with low mitotic activity, typically leading to a favorable prognosis. Conversely, malignant neoplasms contain anaplastic cells with high mitotic activity, and their prognosis is often poor due to aggressive behavior and potential for metastasis .
The WHO's Global Initiative for Childhood Cancer aims to improve survival rates by providing technical assistance to governments, developing high-quality cancer program frameworks, and improving access to essential medicines and technologies. The target goal for 2030 is to achieve a 60% survival rate for all children with cancer globally .
Childhood cancer typically arises from genetic changes in single cells that proliferate into tumors, with genetic predisposition accounting for about 10% of cases. Unlike adult cancers, childhood cancers generally lack known environmental or lifestyle causes. Chronic infections like HIV, Epstein-Barr virus, and malaria pose risks, particularly in LICs. Further research is needed to fully understand other influencing factors .
Chronic infections such as HIV, Epstein-Barr virus, and malaria contribute to the risk of childhood cancer, especially in low-income countries. These infections can lead to cancer pathogenesis by causing chronic inflammation, immunosuppression, and providing an environment conducive to genetic mutations and proliferation of cancerous cells .
A successful early diagnosis program includes raising awareness of symptoms among families and healthcare providers, timely clinical evaluation, accurate diagnosis, and access to prompt treatment. Early diagnosis is critical as it allows prompt intervention, increasing the likelihood of successful treatment and improving outcomes for children with cancer .
In high-income countries (HICs), over 80% of children with cancer achieve a cure, whereas in low-income countries (LICs), less than 30% survive. Contributing factors to this discrepancy include delayed diagnosis, limited access to accurate diagnosis and treatment, treatment abandonment, toxicity-related deaths, and preventable relapses in LICs. Improving access to essential medicines and technologies can feasibly enhance survival rates in these regions .
Benign neoplasms grow slowly and are encapsulated with well-defined boundaries, rarely metastasizing. In contrast, malignant neoplasms grow rapidly, lack well-defined boundaries, are unencapsulated, and frequently metastasize to distant organs .